Publications by authors named "Yuanzhuo Yan"
Article Synopsis
- Ga-DOTA-Ibandronate (Ga-DOTA-IBA) PET/CT is a new imaging method for detecting bone metastases in breast cancer, and this study compares its effectiveness to the traditional Tc-MDP whole-body bone scan (WBBS).
- In a study involving 45 women with breast cancer, Ga-DOTA-IBA PET/CT achieved a 100% detection rate for bone metastases, while Tc-MDP WBBS had a 95.6% detection rate.
- Ga-DOTA-IBA PET/CT also identified a significantly higher number of metastasis lesions (546 total) compared to Tc-MDP WBBS, suggesting it may be a more sensitive technique for assessing bone metastases and guiding further
Purpose: The Ga/Lu-FAP-2286 is a newly developed tumor imaging agent that shows potential for visualizing and treating tumor stroma. The objective of this research was to evaluate the effectiveness of Ga-FAP-2286 PET/CT and F-FDG PET/CT in diagnosing advanced lung cancer.
Methods: In this prospective study, patients with lung cancer who underwent Ga-FAP-2286 and F-FDG PET/CT examinations between September 2022 and June 2023 were analyzed.
Purpose: This study aimed to analyze articles on the diagnosis and treatment of bone and soft tissue sarcoma using positron emission tomography (PET)/computed tomography (CT) published in the last 13 years. The objective was to conduct a bibliometric analysis and identify the research hotspots and emerging trends.
Methods: Web of Science was used to search for articles on PET/CT diagnosis and treatment of bone and soft tissue sarcoma published from January 2010 to June 2023.
Prostate cancer(PCa), a leading global health concern, profoundly impacts millions of men worldwide. Progressing through two stages, it initially develops within the prostate and subsequently extends to vital organs such as lymph nodes, bones, lungs, and the liver. In the early phases, castration therapy is often employed to mitigate androgen effects.
View Article and Find Full Text PDFThe fibroblast activating protein (FAP) is expressed by some fibroblasts found in healthy tissues. However, FAP is overexpressed in more than 90% of epithelial tumors, including breast and gynecological tumors. As a result, the FAP ligand could be used as a target for diagnosis and treatment purposes.
View Article and Find Full Text PDF